Metabolic profile of tunisian obese adult

##plugins.themes.academic_pro.article.sidebar##

Published May 20, 2010
Download
pdf
Vol. 88 No. 6 (2010): Issue Jun 2010

##plugins.themes.academic_pro.article.main##

F Mahjoub
A Gamoudi
H Jamoussi
Sadok Gaigi
Samira Blouza-Chabchoub

Abstract

Background : obesity is associated with multiple comorbidities such us metabolic and cardiovascular diseases.
Aims: Evaluate metabolic profile and to determinate the frequency of metabolic syndrome in Tunisian obese adult.
Methods : It’s a prospective study realized in the unit of obesity research in the national institute of nutrition between April 2003 and March 2005.This study concerned two groups of subjects aged between 20 and 60 years old : Group 1 (n = 100) obese (BMI ³ 30 kg/m2) and group 2 (n= 60) controls with normal weight (BMI between 18,5 and 24,9 kg/m2).
Results : Mean number of metabolic complications is significantly higher (P < 10-3) in obese (3,28 ± 2) than in controls (1,16 ± 1,2). Impaired fasting glucose and type 2 diabetes mellitus are respectively more frequent in obese (37 % and 16 %) than in non obese (5 % et 1,7 %). Hyperinsulinemia is significantly (P<10-3) more frequent in
obese. hypertriglyceridemia, hypercholesterolemia and hyperapolipoproteinaemia B are significantly (P = 0,01, P < 10-3 et P < 10-3) more frequent in obese than in no overweight subjects. The prevalence of hyperuricemia increased significantly (P = 0,01) in overweight subjects than in normal weight subjects. Metabolic syndrome is significantly more frequent (P < 10-3) in obese (48 %) than in control (1,7 %).
Conclusion: Obesity, especially visceral obesity , is associated with a cluster of metabolic complications increasing the risk of coronary heart disease. We stresson the importance of primary prevention and early management of obesity.

Keywords:

visceral obesity, type 2 diabetes, dyslipoproteinaemia, hyperuricemia, metabolic syndrome

##plugins.themes.academic_pro.article.details##

References

  1. Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. European Journal of Internal Medicine 2003;14: 101-6.
  2. Boulogne A, Vantyghem MC. Epidemiological data and screening criteria of the metabolic syndrome. Presse Med 2004 ; 33: 662-5.
  3. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004 ; 89 : 2583-89.
  4. Bruckert E, Giral P. Dyslipoprotéinémies. Traité de Nutrition Clinique de l'adulte. Paris: Flammarion, 2001: 473-84.
  5. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome : Importance of type 2 diabetes and familial combinated hyperlipidemia in cornary artery disease risk. J Clin endocrinol Metab 2004; 89: 2601-7.
  6. Charles MA. Actualités épidémiologiques de l'obésité et du diabète de type 2 en France. Diabetes Metab 2000 ; 26 : 17-20.
  7. De Jongh RT, Serne EH, Ijzerman RG, De Vries G, Stehouwer CD. Impaired microvascular function in obesity : implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004 ; 109 : 2529-35.
  8. El Ouni N. Hépatopathies et autres complications de l'obésité. Thèse de Doctorat en Médecine, Tunis 1998.
  9. Eschwège E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes Metab 2003; 29 : 6S19-6S27.
  10. Formiguera X, Canton A. Obesity: epidemiology and clinical aspects. Best Practice and Research Clinical Gastroenterology 2004 ; 18: 1125-46.
  11. Ghannem H, Maarouf R, Tabka A, Haj Frej A, Marzouki M. La triade obésité, hypertension et troubles de la glycorégulation dans une population semi-urbaine du sahel tunisien. Diabetes Metab 1993 ; 19 : 310-14.
  12. Gomila S, Dallongeville J. Epidémiologie du syndrome métabolique en France. Medecine et nutrition 2003 ; 39 : 89-94.
  13. Grundy SM. Obesity, metabolic syndrome and cardiovascular disease. J Clin endocrinol Metab 2004; 89: 2595-2600.
  14. Hatira A. Fréquence, profil clinique et évolution des complications chez l'obèse tunisien. Thèse de doctorat en Médecine, Tunis 2002.
  15. Hmidi K. Etude du profil clinique et biologique et des facteurs de risque vasculaire chez l'obèse adulte. Thèse de Doctorat en Médecine, Tunis 1996.
  16. Hubert HB et al Obesity as an independent risk factor for cardiovascular disease : a 26 year follow up of participants in the Framingham heart study. Circulation 1983 ; 67 : 968-77.
  17. Janssen I. Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men. Can Med Assoc J 2005; 172 : 1315-16.
  18. Kissebah AH et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982 ; 54 : 254-60.
  19. Knowler WC et al. Reduction in the incidence of type 2diabetes with lifestyle intervention or metformin. N Engl J Med 2002 ; 346 : 393-403.
  20. Lee WJ, Chen HH, Wang W, Wei PL, Lin CM, Huang MT. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc 2003 ; 102: 459-64 [Abstract].
  21. Lemieux S, Després JP. Metabolic complications of visceral obesity: contribution to the aetiology of type 2 diabetes and implications for prevention and treatment. Diabetes Metab 1994 ; 20: 375-93.
  22. Lerario AC et al. Risk factors in obese women, with particular reference to visceral fat component. Diabetes Metab 1997 ; 23 : 68-74.
  23. Marchesini G et al. The metabolic syndrome in treatment seeking obese persons. Metabolism 2004 ; 53: 435-440.
  24. Park YW et al. The metabolic syndrome. Arch Intern Med 2003; 163: 427-36.
  25. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obesity Research 2002 ; 10: 97S-104S.
  26. Rguibi M, Belahsen R. Metabolic syndrome among Moroccan sahraoui adult women. Am J Hum Biol 2004 ; 16: 598-601 [Abstract].
  27. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab 2004 ; 89: 2522-5.
  28. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985 ; 103: 983-8.
  29. Wassef N, Sidhom G, Elk Z, Elk M. Lipoprotein (a) in android obesity and NIDDM. Diabetes Care 1997 ; 20 : 1693-6.
  30. Ziegler O, Debry G. Epidémiologie des obésités de l'adulte. EMC. Endocrinologie-Nutrition 1998 ; 10-506-B-20 : 7p.